Anju Kumari

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma”.

UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.024

N/A

0.550DataRank · unranked

38 citations

Vivek Shukla, Sichuan Xi, Sudheer Kumar Gara, Yi Liu, David M. Straughan +18 more

Role of aspartate 42 and histidine 79 in the aiPLA2 activity and oligomeric status of Prdx6 at low pH

Scientific Reports(2025)10.1038/s41598-025-91218-2

N/A

0.165DataRank · unranked

2 citations

Sharifun Shahnaj, Anju Kumari, Japani Longjam, A. N. Wungnaopam, Khundrakpam Herojit Singh +5 more

Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0790

N/A

0DataRank · unranked

2 citations

Raul Calvo, Anju Kumari, Rushikesh Sable, Yuhong Fang, Dingyin Tao +17 more